Recent research has suggested that MDG-1 could reduce hyperglycemia, hyperinsulinemia and hyperlipidemia in the spontaneous model of type 2 diabetes in ob/ob mice or KKAy mice [14,15,16]. This evidence concerns the gene DNAJB9 and Hyperglycemia.